Table 2.
Absolute and relative frequencies of the main characteristics of the five patients
| Absolute | Relative | Absolute | Relative | ||
|---|---|---|---|---|---|
| Gender | |||||
| - Male | 2/5 | 40% | Microbleeds | 5/5 | 100% |
| - Female | 3/5 | 60% | |||
| Age | |||||
| - > 65 | 5/5 | 100% | PRES | 1/5 | 20% |
| - δ 65 | 0/5 | 0% | |||
| Hypertension | 4/5 | 80% | Cortical siderosis | 5/5 | 100% |
| Dyslipidemia | 2/5 | 40% | White matter hyperintensity | 5/5 | 100% |
| Mellitus diabetes | 1/5 | 20% | Leptomeningeal enhancement | 1/5 | 20% |
| Anticoagulant treatment | 0/5 | 0% | Amyloid spells | 3/5 | 60% |
| Systemic disease | 3/5 | 60% | Alzheimer biomarkers | 4/4 | 100% |
| Clinical syndrome | |||||
| - Parietal | 4/5 | 80% | Methylprednisolone 1000 mg | 4/5 | 80% |
| - Temporal | 1/5 | 20% | |||
| Seizures | 1/5 | 20% | Corticosteroids improvement | 4/4 | 100% |
| Rapidly progressive dementia | 2/5 | 40% | Rankin pre-hospitalization | ||
| - δ2 | 4/5 | 80% | |||
| - > 2 | 1/5 | 20% | |||
| Intracranial hemorrhage | 2/5 | 40% | Ranking post-hospitalization | ||
| - δ2 | 3/5 | 60% | |||
| - > 2 | 2/5 | 40% | |||